Bristol Myers Squibb Integrates AI to Enhance Drug Development Processes
Bristol Myers Squibb is introducing Anthropic's Claude AI model to over 30,000 employees, seeking to reshape drug development and streamline operations.
More from this archive
Anthropic Addresses Claude Code Vulnerability After Researcher Discovery
Anthropic has patched a serious vulnerability in its Claude Code network sandbox that could have allowed attackers to…
Seeking Spaces Beyond AI Saturation in Tech Discussions
As AI continues to overshadow other tech topics, many are searching for forums that foster diverse discussions. Alternatives…
Can Google Elevate AI Agents Beyond Concepts to Useful Tools?
As Google rolls out Gemini Spark, the tech giant hopes to redefine AI agents from theoretical concepts to…
AI Workloads Surge Demand for Data Centres in Indonesia
The demand for data centre infrastructure in Indonesia is skyrocketing due to AI advancements, with liquid cooling solutions…
The archive
sorted by latest
Anthropic’s Valuation Potential: A $1 Trillion Bet on AI Dominance
GPUBeat Desk · 2 min
Older Nvidia GPUs See Rising Demand Amid AI Boom
GPUBeat Desk · 2 min
IBM Enhances Cybersecurity via Anthropic Partnership Amid CISA Speculation
GPUBeat Desk · 2 min
Nvidia Faces Market Challenges Amid Geopolitical Tensions
GPUBeat Desk · 2 min
Jeff Bezos Dismisses AI Bubble Fears, Predicts Long-Term Growth
GPUBeat Desk · 2 min